Martin Behe Selected Research

Martin Behe Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 09/2006
2	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 01/2016
2	Insulinoma 05/2019 - 06/2007
2	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 06/2012
2	Necrosis 06/2012 - 06/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2019
1	Glioma (Gliomas) 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2013
1	Carotid Artery Thrombosis 03/2011
1	Thrombosis (Thrombus) 03/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Neoplasm Metastasis (Metastasis) 12/2010
1	Xerostomia 09/2010
1	Alzheimer Disease (Alzheimer's Disease) 01/2009
1	Cognitive Dysfunction 01/2009
1	Carcinogenesis 06/2007
1	Cataract (Cataracts) 05/2006
1	Capsule Opacification 05/2006

Drug/Important Bio-Agent (IBA)

4	Cholecystokinin B ReceptorIBA 01/2020 - 05/2014
4	minigastrinIBA 01/2020 - 05/2014
3	Radioisotopes (Radionuclides)IBA 01/2020 - 01/2016
3	Peptides (Polypeptides)IBA 01/2020 - 03/2012
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	LigandsIBA 01/2020 - 03/2011
2	PeptidomimeticsIBA 01/2020 - 01/2020
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020 - 01/2011
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2016
2	Exenatide (Byetta)FDA Link 05/2019 - 06/2007
2	Glucagon-Like Peptide-1 ReceptorIBA 05/2019 - 06/2007
2	Biological ProductsIBA 05/2014 - 06/2012
2	EpitopesIBA 02/2014 - 03/2011
1	CytokinesIBA 01/2022
1	Designed Ankyrin Repeat ProteinsIBA 01/2022
1	Fibronectins (Fibronectin)IBA 11/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Everolimus FDA Link 01/2020
1	succinylated gelatinIBA 01/2020
1	aspartyl-phenylalanine (aspartylphenylalanine)IBA 01/2020
1	glycyltryptophanIBA 01/2020
1	alanyltyrosineIBA 01/2020
1	TriazolesIBA 01/2020
1	SolutionsIBA 01/2020
1	AmidesIBA 01/2020
1	cercosporamideIBA 01/2016
1	CGP 57380IBA 01/2016
1	Temozolomide (Temodar)FDA LinkGeneric 01/2016
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2016
1	Eukaryotic Initiation Factor-4EIBA 01/2016
1	Terbium-155IBA 05/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2014
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2014
1	Aligeron (AS 2)IBA 02/2014
1	IntegrinsIBA 04/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2012
1	vadimezanIBA 06/2012
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2012
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 03/2012
1	GastrinsIBA 03/2012
1	Cholecystokinin (Pancreozymin)IBA 03/2012
1	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2011
1	Monoclonal AntibodiesIBA 01/2011
1	AntibodiesIBA 12/2010
1	AC133 AntigenIBA 12/2010
1	AutoantibodiesIBA 01/2009
1	Amyloid beta-PeptidesIBA 01/2009
1	Amyloid (Amyloid Fibrils)IBA 01/2009
1	Therapeutic UsesIBA 06/2007
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2007
1	Pentetic Acid (DTPA)FDA LinkGeneric 06/2007
1	RadiopharmaceuticalsIBA 06/2007
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2006
1	Trastuzumab (Herceptin)FDA Link 09/2006
1	PolyethyleneimineIBA 09/2006
1	Pharmaceutical PreparationsIBA 05/2006
1	PolymersIBA 05/2006

Therapy/Procedure

9	Therapeutics 01/2020 - 06/2007
3	Radiotherapy 01/2016 - 06/2007
1	Intravenous Injections 01/2022
1	Immunotherapy 01/2022
1	Injections 01/2020
1	Drug Therapy (Chemotherapy) 01/2016
1	Adjuvant Chemotherapy 01/2016
1	Transcutaneous Electric Nerve Stimulation (TENS) 05/2006
1	Intraocular Lenses (Intraocular Lens) 05/2006